Benzinga All Access

Mary Spio, CEO & Founder of CEEK Metaverse, was recently a guest on Benzinga’s All Access. CEEK is a metaverse platform that connects users directly to artists and creatives, allowing them to experience live shows, events and other content as if they were there. The platform gives artists...

Dr. Gary S. Jacob, CEO of OKYO Pharma (NASDAQ: OKYO), was recently a guest on Benzinga’s All Access. OKYO Pharma is a biotechnology company focused on the treatment of ocular diseases. OKYO is currently developing OK-101 to treat dry eye disease, which is a currently underserved and untreated...

Howard Berman, Ph.D., CEO & Chairman of the Board of Coya Therapeutics, Inc. (NASDAQ: COYA), was recently a guest on Benzinga’s All Access. Coya is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells, called...

Dennis Calvert, President & CEO of BioLargo, Inc. (OTCQB: BLGO), was recently a guest on Benzinga’s All Access. BioLargo is a cleantech and life sciences innovator and engineering services solution provider. The company’s core products address PFAS contamination, achieve advanced...

Al Altomari, Chairman & CEO of Agile Therapeutics (NASDAQ: AGRX) was recently a guest on Benzinga’s All Access. Agile Therapeutics is a women’s healthcare company “dedicated to fulfilling the unmet needs of today’s women.” The company looks to develop novel...

Chuck Piluso, CEO of Data Storage Corporation (NASDAQ: DTST), was recently a guest on Benzinga’s All Access. Data Storage Corporation is a provider of data recovery and business continuity services that help organizations protect their data, minimize downtime and recover and restore data...

Steve Glover, Co-Founder, Chairman, CEO, & President of ZyVersa Therapeutics, Inc. (NASDAQ: ZVSA), was recently a guest on Benzinga’s All-Access. ZyVersa is a clinical-stage specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class drugs...

Konrad Wasiela, CEO of ESE Entertainment Inc. (OTCQX: ENTEF) (TSXV: ESE), was recently a guest on Benzinga’s All-Access. ESE Entertainment is a technology company that maximizes new user flow for gaming companies. ESE also operates its own ecommerce channels, esports teams, and gaming league...

Dennis Calvert, CEO of BioLargo, Inc. (OTCQB: BLGO) was on Benzinga’s All Access recently. BioLargo is a cleantech and life sciences innovator and engineering services solution provider with core products addressing PFAS contamination and advanced water treatment, as well as removing VOCs....

Robert Stefanovich, CFO of Cryoport, Inc. (NASDAQ: CYRX), was recently a guest on Benzinga’s All-Access. Cryoport is a leading provider of temperature-controlled supply chain solutions for the life sciences and biopharma industries. The company provides end-to-end solutions for clients...

Jerry Griffin, VP of Sales & Marketing at BayMedica, Inc. – a subsidiary of InMed Pharmaceuticals Inc (NASDAQ: INM) – was a guest on Benzinga’s All Access. InMed is a clinical stage biopharma company that develops drugs based on rare cannabinoids. The company has several drugs...

Jake Boyle, Chief Commercial Officer at Caleb & Brown, was recently a guest on Benzinga’s All-Access. Caleb & Brown is a cryptocurrency brokerage that helps its clients navigate the ofttimes turbulent waters of crypto and build wealth. The company has over 22,000 clients and has...

Dr. Ann Marie Sastry, CEO of Amesite Inc (NASDAQ: AMST), was recently a guest on Benzinga’s All Access. Amesite builds artificial-intelligence software products designed to improve learning. The company says that with their products learning is more affordable, accessible and engaging....

Vin Singh, Founder and CEO of BullFrog AI Holdings, Inc. (NASDAQ: BFRG), was recently a guest on Benzinga’s All Access. BullFrog AI is a clinical-phase biotechnology company using machine learning to advance medicine and improve human health. The company uses technology developed in the...

Sylvia Wulf, President and CEO of AquaBounty Technologies, Inc. (NASDAQ: AQB), was recently interviewed by Benzinga. AquaBounty uses innovative land-based farming technology and advanced genetics to grow the world's seafood supply more efficiently and sustainably. The company believes that...